Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
Background: Available neuroendocrine biomarkers are considered to have insufficient accuracy to discriminate patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) from healthy controls. Recent studies have demonstrated a potential role for circulating neuroendocrine specific transc...
Main Authors: | Mark J. C. van Treijen, Catharina M. Korse, Rachel S. van Leeuwaarde, Lisette J. Saveur, Menno R. Vriens, Wieke H. M. Verbeek, Margot E. T. Tesselaar, Gerlof D. Valk |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00740/full |
Similar Items
-
Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
by: Sonja Levy, et al.
Published: (2020-08-01) -
Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors
by: Muhammad Wasif Saif, et al.
Published: (2018-10-01) -
‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1
by: Dirk-Jan van Beek, et al.
Published: (2018-10-01) -
The Importance of an Early and Accurate MEN1 Diagnosis
by: Joanne M. de Laat, et al.
Published: (2018-09-01) -
Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
by: Huiying Shi, et al.
Published: (2020-09-01)